Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice

J Cell Biochem. 2003 Oct 1;90(2):347-60. doi: 10.1002/jcb.10620.

Abstract

We studied the beneficial effects of dietary consumption of n-3 polyunsaturated fatty acids (PUFA) and two selective estrogen receptor modulator (SERM) derivatives (SERM-I and SERM-II) and their combined effect on serum lipids, skin dermis and adipose layers, bone marrow adipogenesis, and cytokine secretion in mice. Two different ovariectomized (OVX) models were studied: treatment began immediately post-OVX in one and 3 months post-OVX in the other. Our results showed that n-3 PUFA and both SERMs decreased triglyceride levels in the serum, and that SERMs also decreased serum cholesterol levels while n-3 PUFA had no similar effect. SERMs had no effect on IL-6, IL-1 beta, or IL-10 levels, but they decreased ex vivo tumor necrosis factor (TNF-alpha). N-3 PUFA decreased secretion of non-induced IL-6 and TNF-alpha from cultured BMC and IL-1 beta levels in vivo (i.e., in bone marrow plasma), but its main effect was a significant elevation in the secretion of IL-10, a known anti-inflammatory cytokine. OVX-induced B-lymphopoiesis was not affected by LY-139481 (SERM-I) while LY-353381 (SERM-II) exhibited an estrogen-antagonistic effect in sham and OVX mice and elevated the amount of B-cells in bone marrow. Fish oil consumption prevented the elevation in B-lymphopoiesis caused by OVX, but had no curative effect on established augmented B-lymphopoiesis. This activity could be mediated via the elevation of IL-10 which was shown to suppress B-lymphopoiesis. Both SERMs and n-3 PUFA inhibited the increase in adipose tissue thickness caused by OVX in mice. Our results showed that n-3 PUFA, could prevent some of the deleterious outcomes of estrogen deficiency that were not affected by SERMs. We observed no significant beneficial effects of the combined administration of SERM-I, SERM-II, and PUFA on the studied parameters.The exact mechanism by which polyunsaturated fatty acids exert their activities is still not clear, but peroxisome proliferator-activated receptors (PPARs) might be involved in processes which are modulated by n-3 PUFA.

MeSH terms

  • Adipose Tissue / metabolism
  • Animals
  • Body Weight / drug effects
  • Bone Marrow Cells / metabolism
  • Cholesterol / blood
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated / pharmacology*
  • Female
  • Fish Oils
  • Hypolipidemic Agents / pharmacology*
  • Interleukin-1 / metabolism
  • Interleukin-10 / metabolism
  • Interleukin-6 / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Ovariectomy*
  • Ovary / physiology*
  • Piperidines / pharmacology
  • Raloxifene Hydrochloride / pharmacology
  • Selective Estrogen Receptor Modulators / pharmacology*
  • Skin / drug effects
  • Skin / metabolism
  • Spleen / metabolism
  • Thiophenes / pharmacology
  • Triglycerides / blood
  • Triglycerides / pharmacology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated
  • Fish Oils
  • Hypolipidemic Agents
  • Interleukin-1
  • Interleukin-6
  • Piperidines
  • Selective Estrogen Receptor Modulators
  • Thiophenes
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Pikasol
  • Interleukin-10
  • Raloxifene Hydrochloride
  • Cholesterol
  • LY 353381